Cargando…
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of High-Dose Rebamipide Treatment for Low-Dose Aspirin-Induced Moderate-to-Severe Small Intestinal Damage
BACKGROUND: Low-dose aspirin (LDA) frequently causes small bowel injury. While some drugs have been reported to be effective in treating LDA-induced small intestinal damage, most studies did not exclude patients with mild damage thought to be clinically insignificant. AIM: We conducted a multicenter...
Autores principales: | Watanabe, Toshio, Takeuchi, Toshihisa, Handa, Osamu, Sakata, Yasuhisa, Tanigawa, Tetsuya, Shiba, Masatsugu, Naito, Yuji, Higuchi, Kazuhide, Fujimoto, Kazuma, Yoshikawa, Toshikazu, Arakawa, Tetsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398323/ https://www.ncbi.nlm.nih.gov/pubmed/25874951 http://dx.doi.org/10.1371/journal.pone.0122330 |
Ejemplares similares
-
Determination of the adequate dosage of rebamipide, a gastric mucoprotective drug, to prevent low-dose aspirin-induced gastrointestinal mucosal injury
por: Ota, Kazuhiro, et al.
Publicado: (2016) -
Long-term efficacy and safety of rabeprazole in patients taking low-dose
aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel-group,
multicenter, extension clinical trial
por: Fujishiro, Mitsuhiro, et al.
Publicado: (2015) -
Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms
por: Mizukami, Kazuhiro, et al.
Publicado: (2012) -
Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase
por: Tanigawa, Tetsuya, et al.
Publicado: (2011) -
Transcriptome Analysis for Cytoprotective Actions of Rebamipide against Indomethacin-Induced Gastric Mucosal Injury in Rats
por: Naito, Yuji, et al.
Publicado: (2007)